Qube Research & Technologies (QRT)
ARVN icon

Qube Research & Technologies (QRT)’s Arvinas ARVN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
1,592,276
+390,641
+33% +$3.64M 0.01% 1127
2026
Q1 		$12.7M Sell
1,201,635
-123,105
-9% -$1.52M 0.01% 1135
2025
Q4 		$15.7M Sell
1,324,740
-162,124
-11% -$1.77M 0.02% 1047
2025
Q3 		$12.7M Buy
1,486,864
+903,337
+155% +$6.85M 0.01% 1173
2025
Q2 		$4.29M Buy
583,527
+357,155
+158% +$2.63M ﹤0.01% 1798
2025
Q1 		$1.59M Buy
226,372
+150,174
+197% +$2.35M ﹤0.01% 2061
2024
Q4 		$1.46M Sell
76,198
-133,711
-64% -$3.25M ﹤0.01% 2013
2024
Q3 		$5.17M Sell
209,909
-89,836
-30% -$2.35M 0.01% 1372
2024
Q2 		$7.98M Buy
299,745
+185,344
+162% +$5.91M 0.01% 1038
2024
Q1 		$4.72M Buy
114,401
+104,203
+1,022% +$4.55M 0.01% 1265
2023
Q4 		$420K Buy
+10,198
New +$238K ﹤0.01% 2393
2022
Q3 		– Sell
-14,424
Closed -$607K – 2489
2022
Q2 		$607K Buy
+14,424
New +$724K ﹤0.01% 1331
2021
Q2 		– Sell
-6,986
Closed -$462K – 2244
2021
Q1 		$462K Buy
+6,986
New +$534K 0.01% 1227
2020
Q1 		– Sell
-8,971
Closed -$369K – 1117
2019
Q4 		$369K Buy
+8,971
New +$263K 0.01% 1111

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ARVN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Arvinas (ARVN) stake by 33% in Q2 2026, buying an estimated $3.64M and bringing the position to 1,592,276 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #1127.

Qube Research & Technologies (QRT) first reported a position in ARVN in Q4 2019 and has held it in 14 quarters since. The position peaked at $15.7M in Q4 2025. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,592,276 shares of Arvinas worth $13.2M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 390,641 Arvinas shares in Q2 2026, an estimated $3.64M.
  • Arvinas made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1127 holding.
  • Qube Research & Technologies (QRT) first reported a position in Arvinas in Q4 2019 and has held it in 14 quarters since.
  • Qube Research & Technologies (QRT)'s Arvinas position peaked at $15.7M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.